AAPL332.77+0.50 (+0.15%) ▲|ABBV261.89+4.77 (+1.86%) ▲|ABT103.10+1.15 (+1.13%) ▲|ACN190.40+6.50 (+3.53%) ▲|ADBE262.85+10.62 (+4.21%) ▲|AMAT431.29-25.20 (-5.52%) ▼|AMD491.32-24.81 (-4.81%) ▼|AMGN379.28+1.93 (+0.51%) ▲|AMT177.33-0.52 (-0.29%) ▼|AMZN253.97-2.81 (-1.09%) ▼|AVGO347.41-14.58 (-4.03%) ▼|AXP325.23+0.54 (+0.16%) ▲|BA209.45-1.00 (-0.48%) ▼|BAC61.70-1.00 (-1.59%) ▼|BKNG175.91+1.99 (+1.14%) ▲|BLK1,066.20-13.46 (-1.25%) ▼|BMY64.19+0.55 (+0.86%) ▲|BNY159.54-3.12 (-1.92%) ▼|BRK-B513.71+3.34 (+0.65%) ▲|C134.54-4.28 (-3.08%) ▼|CAT786.89-31.68 (-3.87%) ▼|CL88.32+1.52 (+1.75%) ▲|CMCSA25.08-0.13 (-0.50%) ▼|COF205.93-2.37 (-1.14%) ▼|COP138.16+0.81 (+0.59%) ▲|COST916.02+11.25 (+1.24%) ▲|CRM256.53+8.81 (+3.56%) ▲|CSCO110.96-1.17 (-1.04%) ▼|CVS95.35+0.69 (+0.72%) ▲|CVX214.42+0.36 (+0.17%) ▲|DE687.34+11.60 (+1.72%) ▲|DHR199.93-0.21 (-0.10%) ▼|DIS108.66+2.11 (+1.98%) ▲|DUK118.78-0.64 (-0.54%) ▼|EMR147.94-4.26 (-2.80%) ▼|FDX312.60+1.83 (+0.59%) ▲|GD357.05+1.15 (+0.32%) ▲|GE317.11-6.55 (-2.02%) ▼|GEV876.00-81.27 (-8.49%) ▼|GILD145.53+1.81 (+1.26%) ▲|GM86.22+0.60 (+0.70%) ▲|GOOG342.05+6.60 (+1.97%) ▲|GOOGL345.39+6.89 (+2.03%) ▲|GS1,000.43-28.75 (-2.79%) ▼|HD309.87+1.13 (+0.36%) ▲|HON199.26-3.11 (-1.53%) ▼|IBM247.76+4.47 (+1.84%) ▲|INTC97.90-5.04 (-4.90%) ▼|INTU338.12+16.55 (+5.15%) ▲|ISRG374.04+4.89 (+1.32%) ▲|JNJ268.52+2.94 (+1.11%) ▲|JPM350.88-5.35 (-1.50%) ▼|KO88.91+0.62 (+0.70%) ▲|LIN462.96-3.27 (-0.70%) ▼|LLY1,146.89+31.19 (+2.80%) ▲|LMT529.15+4.96 (+0.95%) ▲|LOW197.92+1.10 (+0.56%) ▲|LRCX277.89-20.33 (-6.82%) ▼|MA575.11+5.92 (+1.04%) ▲|MCD257.99+5.46 (+2.16%) ▲|MDLZ62.29-0.15 (-0.24%) ▼|MDT93.12+2.16 (+2.37%) ▲|META659.63+11.60 (+1.79%) ▲|MMM160.99-3.98 (-2.41%) ▼|MO70.54+1.56 (+2.25%) ▲|MRK144.78+0.85 (+0.59%) ▲|MS209.52-4.87 (-2.27%) ▼|MSFT505.28+9.65 (+1.95%) ▲|MU924.41-50.85 (-5.21%) ▼|NEE81.85-0.47 (-0.56%) ▼|NFLX80.37+2.97 (+3.84%) ▲|NKE37.22+0.42 (+1.13%) ▲|NOW141.65+9.12 (+6.88%) ▲|NVDA211.93-6.36 (-2.91%) ▼|ORCL144.70-5.59 (-3.72%) ▼|PEP136.24-0.08 (-0.06%) ▼|PFE27.77+0.05 (+0.19%) ▲|PG146.06+0.79 (+0.54%) ▲|PLTR171.55+4.32 (+2.58%) ▲|PM193.36+2.30 (+1.20%) ▲|QCOM178.71-3.26 (-1.79%) ▼|RTX195.24-2.44 (-1.23%) ▼|SBUX98.44-0.30 (-0.30%) ▼|SCHW107.43+0.18 (+0.17%) ▲|SO86.82-0.35 (-0.40%) ▼|SPG206.10+1.27 (+0.62%) ▲|T26.28+0.22 (+0.84%) ▲|TMO607.77-2.05 (-0.34%) ▼|TMUS183.13+0.80 (+0.44%) ▲|TSLA363.34-2.10 (-0.57%) ▼|TXN263.67-5.03 (-1.87%) ▼|UBER72.27+0.60 (+0.84%) ▲|UNH384.35+7.58 (+2.01%) ▲|UNP283.89-0.52 (-0.18%) ▼|UPS101.70+1.42 (+1.42%) ▲|USB62.82-0.02 (-0.03%) ▼|V376.00+5.55 (+1.50%) ▲|VZ51.13+0.52 (+1.02%) ▲|WFC88.54-1.75 (-1.94%) ▼|WMT109.06+1.91 (+1.78%) ▲|XOM165.91-0.09 (-0.05%) ▼|AAPL332.77+0.50 (+0.15%) ▲|ABBV261.89+4.77 (+1.86%) ▲|ABT103.10+1.15 (+1.13%) ▲|ACN190.40+6.50 (+3.53%) ▲|ADBE262.85+10.62 (+4.21%) ▲|AMAT431.29-25.20 (-5.52%) ▼|AMD491.32-24.81 (-4.81%) ▼|AMGN379.28+1.93 (+0.51%) ▲|AMT177.33-0.52 (-0.29%) ▼|AMZN253.97-2.81 (-1.09%) ▼|AVGO347.41-14.58 (-4.03%) ▼|AXP325.23+0.54 (+0.16%) ▲|BA209.45-1.00 (-0.48%) ▼|BAC61.70-1.00 (-1.59%) ▼|BKNG175.91+1.99 (+1.14%) ▲|BLK1,066.20-13.46 (-1.25%) ▼|BMY64.19+0.55 (+0.86%) ▲|BNY159.54-3.12 (-1.92%) ▼|BRK-B513.71+3.34 (+0.65%) ▲|C134.54-4.28 (-3.08%) ▼|CAT786.89-31.68 (-3.87%) ▼|CL88.32+1.52 (+1.75%) ▲|CMCSA25.08-0.13 (-0.50%) ▼|COF205.93-2.37 (-1.14%) ▼|COP138.16+0.81 (+0.59%) ▲|COST916.02+11.25 (+1.24%) ▲|CRM256.53+8.81 (+3.56%) ▲|CSCO110.96-1.17 (-1.04%) ▼|CVS95.35+0.69 (+0.72%) ▲|CVX214.42+0.36 (+0.17%) ▲|DE687.34+11.60 (+1.72%) ▲|DHR199.93-0.21 (-0.10%) ▼|DIS108.66+2.11 (+1.98%) ▲|DUK118.78-0.64 (-0.54%) ▼|EMR147.94-4.26 (-2.80%) ▼|FDX312.60+1.83 (+0.59%) ▲|GD357.05+1.15 (+0.32%) ▲|GE317.11-6.55 (-2.02%) ▼|GEV876.00-81.27 (-8.49%) ▼|GILD145.53+1.81 (+1.26%) ▲|GM86.22+0.60 (+0.70%) ▲|GOOG342.05+6.60 (+1.97%) ▲|GOOGL345.39+6.89 (+2.03%) ▲|GS1,000.43-28.75 (-2.79%) ▼|HD309.87+1.13 (+0.36%) ▲|HON199.26-3.11 (-1.53%) ▼|IBM247.76+4.47 (+1.84%) ▲|INTC97.90-5.04 (-4.90%) ▼|INTU338.12+16.55 (+5.15%) ▲|ISRG374.04+4.89 (+1.32%) ▲|JNJ268.52+2.94 (+1.11%) ▲|JPM350.88-5.35 (-1.50%) ▼|KO88.91+0.62 (+0.70%) ▲|LIN462.96-3.27 (-0.70%) ▼|LLY1,146.89+31.19 (+2.80%) ▲|LMT529.15+4.96 (+0.95%) ▲|LOW197.92+1.10 (+0.56%) ▲|LRCX277.89-20.33 (-6.82%) ▼|MA575.11+5.92 (+1.04%) ▲|MCD257.99+5.46 (+2.16%) ▲|MDLZ62.29-0.15 (-0.24%) ▼|MDT93.12+2.16 (+2.37%) ▲|META659.63+11.60 (+1.79%) ▲|MMM160.99-3.98 (-2.41%) ▼|MO70.54+1.56 (+2.25%) ▲|MRK144.78+0.85 (+0.59%) ▲|MS209.52-4.87 (-2.27%) ▼|MSFT505.28+9.65 (+1.95%) ▲|MU924.41-50.85 (-5.21%) ▼|NEE81.85-0.47 (-0.56%) ▼|NFLX80.37+2.97 (+3.84%) ▲|NKE37.22+0.42 (+1.13%) ▲|NOW141.65+9.12 (+6.88%) ▲|NVDA211.93-6.36 (-2.91%) ▼|ORCL144.70-5.59 (-3.72%) ▼|PEP136.24-0.08 (-0.06%) ▼|PFE27.77+0.05 (+0.19%) ▲|PG146.06+0.79 (+0.54%) ▲|PLTR171.55+4.32 (+2.58%) ▲|PM193.36+2.30 (+1.20%) ▲|QCOM178.71-3.26 (-1.79%) ▼|RTX195.24-2.44 (-1.23%) ▼|SBUX98.44-0.30 (-0.30%) ▼|SCHW107.43+0.18 (+0.17%) ▲|SO86.82-0.35 (-0.40%) ▼|SPG206.10+1.27 (+0.62%) ▲|T26.28+0.22 (+0.84%) ▲|TMO607.77-2.05 (-0.34%) ▼|TMUS183.13+0.80 (+0.44%) ▲|TSLA363.34-2.10 (-0.57%) ▼|TXN263.67-5.03 (-1.87%) ▼|UBER72.27+0.60 (+0.84%) ▲|UNH384.35+7.58 (+2.01%) ▲|UNP283.89-0.52 (-0.18%) ▼|UPS101.70+1.42 (+1.42%) ▲|USB62.82-0.02 (-0.03%) ▼|V376.00+5.55 (+1.50%) ▲|VZ51.13+0.52 (+1.02%) ▲|WFC88.54-1.75 (-1.94%) ▼|WMT109.06+1.91 (+1.78%) ▲|XOM165.91-0.09 (-0.05%) ▼|
22.2 C
New York
Monday, September 14, 2026

Technology

New Mud Springs Trail System Opens Near Moab, Expanding World-Class Mountain Biking Opportunities

New race-ready trail system adds to the Moab area's renowned mountain biking offerings with trailsfor youth racing, adaptive cyclists, families and riders of varying abilitiesMOAB, Utah, Sept. 11, 2026...

Achieve Publishes New Online Guidance for Freedom Debt Relief and Achieve Customers

SAN MATEO, Calif., Sept. 11, 2026 /PRNewswire/ -- Today, Achieve announced the publication of a...

Olymel brand Chicken Breast Strips recalled due to Listeria monocytogenes

OTTAWA, ON, Sept. 11, 2026 /CNW/ -- Product: Chicken Breast StripsIssue: Food - Microbial contamination...

PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study

BOSTON, Sept. 11, 2026 /PRNewswire/ -- PerZeption Inc. has been awarded a Phase I...

TARGA CLOSES FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT FOR AGGREGATE GROSS PROCEEDS OF C$3,191,935

/NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S....

NET POWER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power...

NEW ORLEANS, June 04, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against NET Power Inc. ("Net Power" or the "Company") (NYSE: NPWR), if they purchased the Company’s securities between June 9, 2023 and March 7, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of North Carolina.

Arctic Wolf Expands into Singapore to Meet Rising Demand for AI-Powered Security Operations

Launch continues Arctic Wolf’s Asia-Pacific expansion with Ingram Micro serving as inaugural distributor in Singapore
Launch continues Arctic Wolf’s Asia-Pacific expansion with Ingram Micro serving as inaugural distributor in Singapore

ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co....

NEW ORLEANS, June 04, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon & Co. (NYSE: OGN), if they purchased the Company’s securities between October 31, 2024 and April 30, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.

IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics,...

NEW ORLEANS, June 04, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 15, 2025 to file lead plaintiff applications in a securities class action lawsuit against Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NasdaqGM: IOVA), if they purchased the Company’s securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Astellas Chooses Veeva Vault CRM as Global Standard

Vault CRM will support Astellas' commercial agility and execution SINGAPORE, June 5, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Astellas has chosen Veeva...

FaceTec, Inc. Awarded Two Additional Patents for Identity Verification Security

Total of 39 issued patents with 33 pending, further strengthening its leading IP portfolio SUMMERLIN, Nev., June 4, 2025 /PRNewswire/ -- FaceTec, Inc., a world...

Derivita Collaborates with Texas Instruments to Advance High-Quality Math in the Thinking Classroom Through Seamless Integration

Derivita's all-in-one math support, assessment, and analytics platform now connects with the TI-Nspire™ CX II graphing calculator—enhancing engagement, minimizing distractions, and powering real-time, high-quality...

Britive Helps to Pioneer the Future of Agentic Identity and Security Platform (AISP) Category, as identified by Aragon Research

Independent Research Firm Highlights Urgent Need to Secure Proliferating AI Agents and Agentic Systems; Forecasts AISP Market to Reach $32.9 Billion by 2031 GLENDALE, Calif.,...

Made4net and Flymingo Announce Partnership to Revolutionize Warehouse Operations with AI-Driven Computer Vision

Partnership brings new visibility capabilities into every activity, delivering immediate impact on SOP process adherence and boosting operational excellence TEANECK, N.J., June 4, 2025 /PRNewswire/...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.